AstraZeneca signs $555 million gene-editing deal with Algen - Stock Watch Index

AstraZeneca signs $555 million gene-editing deal with Algen

October 6, 2025

AstraZeneca signs $555 million gene-editing deal with Algen – report

Search

RECENT PRESS RELEASES

Meta shares slide after company projects higher expenses for 2026

SWI Editorial Staff2025-10-29T15:54:13-07:00October 29, 2025|

Meta shares sink as $16 bn US tax charge tanks profit

SWI Editorial Staff2025-10-29T15:53:42-07:00October 29, 2025|

Meta reports mixed financial results amid spree of AI hiring and spending

SWI Editorial Staff2025-10-29T15:53:20-07:00October 29, 2025|

Meta Stock Plunges as Profits Take $16B Tax Hit From Trump’s ‘One Big Beautiful Bill’

SWI Editorial Staff2025-10-29T15:52:53-07:00October 29, 2025|

After-market movers: Nasdaq futures inch up as Alphabet rises, Microsoft & Meta slip

SWI Editorial Staff2025-10-29T15:52:29-07:00October 29, 2025|

Stocks making the biggest moves after hours: Alphabet, Meta, Starbucks, Microsoft and more

SWI Editorial Staff2025-10-29T15:52:02-07:00October 29, 2025|

Related Post